Brokerage Firm Rating on Medtronic plc (MDT)

Medtronic plc (MDT) : 19 analysts are covering Medtronic plc (MDT) and their average rating on the stock is 1.82, which is read as a Buy. 11 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Medtronic plc (MDT) also receives 2 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 2, which recommends a Buy affirms that they expect a large upside in the stock from the current levels. However, 1 analysts consider that the stock has more downward risks ahead, hence, they suggest a Strong Sell on the stock. A total of 5 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Medtronic plc (MDT) : 14 investment research analysts covering Medtronic plc (MDT) have an average price target of $89.39 for the near short term. The highest target price given by the Brokerage Firm to the stock is $104 and the lowest target is $56 for the short term. Analysts expect the variance to be within $11.4 of the average price.


For the current week, the company shares have a recommendation consensus of Buy. Medtronic plc (NYSE:MDT): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $87.32 and $87.11 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $87.94. The buying momentum continued till the end and the stock did not give up its gains. It closed at $87.80, notching a gain of 0.58% for the day. The total traded volume was 2,919,592 . The stock had closed at $87.29 on the previous day.

In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (EVP, President, MITG) of Medtronic Plc, Hanson Bryan C had sold 15,000 shares worth of $1,305,000 in a transaction dated July 26, 2016. In this transaction, 15,000 shares were sold at $87 per share.

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.